Mammoth Biosciences
Overview
Our fundamental innovations on CRISPR cargo size and novel editing modalities are designed to overcome the delivery challenges for in vivo gene editing and beyond.
We are scientists, engineers, entrepreneurs, and dreamers who are building the CRISPR platform to deliver on the full promise of genetic medicine.
With a distinguished team including co-founder and CRISPR co-inventor Jennifer Doudna, we are investing deeply in novel science to overcome the grand challenges of the CRISPR field and meet unmet patient needs for serious diseases.